Overview
- A new Science Progress review links GLP-1 medicines to hair loss, with the strongest signals at higher doses for obesity and during fast weight loss.
- A 2025 meta-analysis of 34 studies with more than 84,000 participants found users were about 3.4 times more likely to report hair loss than nonusers.
- Doctors say the shedding often reflects rapid calorie cuts that deplete protein, iron, and vitamin B12 rather than a direct toxic effect of the drugs.
- Clinicians recommend steady loss, balanced meals, and topical minoxidil for active shedding, noting most cases are temporary telogen effluvium or faster thinning in people prone to pattern hair loss.
- Separate reviews report rapid weight regain after stopping GLP-1 therapy, with weight often returning near baseline in about 18 months, a pattern drugmakers cite to argue obesity requires long-term treatment.